VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $235,000 | -17.3% | 25,207 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $284,000 | -12.9% | 25,207 | +10.7% | 0.00% | +50.0% |
Q4 2014 | $326,000 | -89.5% | 22,771 | -88.1% | 0.00% | -87.5% |
Q2 2014 | $3,097,000 | +55.1% | 191,435 | +55.9% | 0.02% | +60.0% |
Q1 2014 | $1,997,000 | +33.0% | 122,810 | +1.4% | 0.01% | +11.1% |
Q4 2013 | $1,502,000 | – | 121,066 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |